Welcome to our dedicated page for Health Catalyst news (Ticker: HCAT), a resource for investors and traders seeking the latest updates and insights on Health Catalyst stock.
Health Catalyst, Inc. (Nasdaq: HCAT) is a leading provider of data and analytics technology and services to healthcare organizations. Founded by healthcare veterans, the company specializes in building comprehensive data warehousing and process improvement solutions, aiming to significantly enhance healthcare delivery. Health Catalyst's innovative solutions are powered by its adaptive data architecture, which uses a late-binding bus model for agile and quick implementation.
The company operates primarily through two segments: Technology and Professional Services. The Technology segment is the key revenue driver, providing data platforms, analytics applications, and support services under cloud-based subscriptions, time-based licenses, and maintenance agreements. The Professional Services segment offers analytics, implementation, strategic advisory, outsourcing, and improvement services, enabling clients to maximize the utility of Health Catalyst's technological offerings.
Health Catalyst has recently gained recognition with several achievements:
- VitalCDM: Ranked number one in the Revenue Cycle - Chargemaster Management category of the 2024 Best in KLAS: Software & Services.
- MeasureAble™: Achieved ONC-Health IT 2015 Edition Certification, allowing its use for various quality reporting programs.
- Able Health Registry: Received QPP Qualified Registry approval for the 2024 performance year from CMS.
- Acquisition of Carevive Systems: Strengthened their capabilities in oncology data analytics, improving patient care and outcomes.
Financially, Health Catalyst continues to show promising trends, with forward-looking revenue and EBITDA guidance indicating growth. The company frequently updates its investors through quarterly earnings calls and reports, reflecting transparency and financial health.
Health Catalyst envisions a future where all healthcare decisions are data-informed, leveraging a cloud-based data platform encompassing over 100 million patient records and trillions of data points. This commitment to data-informed decision-making is at the core of its mission to drive measurable improvements in clinical, financial, and operational metrics for healthcare organizations.
For more information, visit the Health Catalyst Investor Relations page.
Health Catalyst (Nasdaq: HCAT) will announce its fourth quarter and full year 2020 operating results on February 25, 2021, after market close. A conference call will be held at 5 p.m. E.T. on the same day to discuss the results. The call can be accessed by U.S. participants at 1-877-295-1104 or 1-470-495-9486 internationally, using participant code 3180522. An online audio webcast will also be available. Health Catalyst specializes in data and analytics technology for healthcare, aiming for data-informed healthcare decisions.
Vitalware by Health Catalyst announced that its chargemaster management solution, VitalCDM, has ranked number one in the Revenue Cycle - Chargemaster Management category of the 2021 Best in KLAS Awards. This marks the third consecutive year VitalCDM has received this accolade. The recognition stemmed from client feedback in 2020, highlighting client satisfaction, functionality, and support. This achievement underscores VitalCDM's ability to enhance operational efficiency, ensure compliance, and improve reimbursement accuracy for hospitals amidst challenging economic conditions.
Health Catalyst (Nasdaq: HCAT) announced the re-appointment of Stephen Grossbart, Ph.D., as a member of the National Quality Forum's Primary Care and Chronic Illness Standing Committee on Jan. 11, 2021. Grossbart has been on the committee since 2017, contributing to significant healthcare quality measures amid ongoing challenges like the coronavirus pandemic. The committee oversees important healthcare measures, crucial for improving treatment outcomes for chronic and infectious diseases.
Transformation Capital Partners has launched its oversubscribed growth equity fund, Transformation Capital Fund II, with $500 million in capital commitments. This fund targets investments in commercial-stage digital health companies aiming to improve healthcare efficiency and consumer access. The firm, managing over $800 million across its funds, leverages its deep industry expertise and extensive healthcare network to support digital health entrepreneurs. The pandemic has accelerated the adoption of digital health solutions across the sector, positioning Transformation Capital as a key partner for growth.
Health Catalyst (Nasdaq: HCAT) will participate in the 39th Annual J.P. Morgan Healthcare Conference from January 11-14, 2021. CEO Dan Burton and CFO Bryan Hunt will present on January 11 at 5:20 p.m. EST. The conference will be held virtually, allowing broader access to healthcare stakeholders. An audio replay of their presentation will be available on the company's investor relations website. Health Catalyst is known for its advanced data and analytics solutions aimed at improving healthcare outcomes through informed decision-making.
Health Catalyst, a leading healthcare data and analytics provider, will participate in three upcoming investor conferences. Executives Patrick Nelli, Bryan Hunt, and Adam Brown are scheduled to present at the following events: the Piper Sandler 32nd Annual Virtual Healthcare Conference on December 2, 2020; the Evercore ISI HealthCONx Conference on December 3, 2020, at 4:20 p.m. EST; and the Guggenheim Digital Health Virtual Conference on December 8, 2020, at 3:15 p.m. EST, with one-on-one meetings on December 9. More details are available on their investor relations page.
Health Catalyst, Inc. (Nasdaq: HCAT) reported its Q3 2020 financial results, showing a 20% year-over-year revenue increase to $47.2 million. Technology revenue grew by 32% to $28.0 million, while professional services revenue rose by 5%. Despite these gains, the company faced a net loss of $27.3 million, up from $21.4 million in Q3 2019. Adjusted EBITDA improved by 24%. Leadership changes were also announced, with Patrick Nelli becoming President, and Bryan Hunt appointed CFO, effective January 1, 2021. The company's outlook remains focused on growth and expanding customer relationships.
Health Catalyst (Nasdaq: HCAT) announced the promotion of Bryan Hunt to Chief Financial Officer effective January 1, 2021. Current CFO Patrick Nelli will transition to President, overseeing growth functions and client engagement. Nelli, instrumental in the company’s IPO, emphasized a commitment to enhancing healthcare transformation. Additionally, Jason Alger and Adam Brown have received promotions within the finance team. CEO Dan Burton expressed confidence in the leadership changes to drive HCAT's mission of improving healthcare through data and analytics.
Health Catalyst, a notable provider of data and analytics solutions for healthcare, announced that CFO Patrick Nelli and SVP Adam Brown will participate in the 29th Annual Credit Suisse Virtual Healthcare Conference on November 12, 2020, featuring a fireside chat at 2:45 p.m. ET. A live audio webcast and replay will be accessible on their investor relations website. Health Catalyst aims to enhance healthcare decisions through its cloud-based platform, which harnesses data from over 100 million patient records, driving improvements in clinical, financial, and operational outcomes.
Health Catalyst (Nasdaq: HCAT) announced a strategic partnership with Middle East Healthcare Company (MEA HCO) to service six Saudi German Hospitals in Saudi Arabia. This multi-year collaboration involves implementing Health Catalyst's DOS™ technology to enhance patient care and reduce costs. The partnership is supported by Topmed, a Dubai-based healthcare consulting firm, which will provide expertise in analytics and operational improvements. This collaboration aligns with Saudi German's commitment to advanced healthcare technologies and aims to drive measurable healthcare improvements.
FAQ
What is the current stock price of Health Catalyst (HCAT)?
What is the market cap of Health Catalyst (HCAT)?
What does Health Catalyst, Inc. do?
What are the main segments of Health Catalyst's business?
What recent achievements has Health Catalyst made?
What is the adaptive data architecture?
How does Health Catalyst generate its revenue?
What is the Best in KLAS ranking?
What is the significance of the MeasureAble™ ONC-Health IT certification?
How does the acquisition of Carevive Systems benefit Health Catalyst?
How does Health Catalyst support its clients?
Where can I find more information about Health Catalyst's financial performance?
